Capsovision Inc stock is traded at $6.11, with a volume of 178,651. It is down -3.17% in the last 24 hours and down -8.53% over the past month. CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
Previous Close:
$6.31
Open:
$6.26
24h Volume:
178,651
Relative Volume:
1.39
Market Cap:
$327.56M
Revenue:
$13.56M
Net Income/Loss:
-$26.97M
P/E Ratio:
-
EPS:
-$0.5742
Net Cash Flow:
-$24.04M
1W Performance:
+1.33%
1M Performance:
-8.53%
6M Performance:
-5.71%
1Y Performance:
+14.63%
1-Day Range:
$6.01$6.37
1-Week Range:
$6.00$6.87
52-Week Range:
$4.50$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision IncSector
HealthcareIndustry
Medical DevicesPhone
(408) 370-4790Address
18805 COX AVENUE SUITE 250, SARATOGA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS